| Target Validation Information | |||||
|---|---|---|---|---|---|
| TTD ID | T87875 | ||||
| Target Name | Glucagon receptor messenger RNA (GCGR mRNA) | ||||
| Type of Target |
Clinical trial |
||||
| Action against Disease Model | ISIS 325568 | Drug Info | ISIS 325568, is a second generation antisense drug that inhibits the body's ability to produce the excessive amounts of glucose. ISIS 325568 inhibits the expression of GCGR leading to a reduction in the ability of glucagon to produce glucose and cancelling out a lack of sensitivity to insulin. | ||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.